Thermo Fisher Scientific Inc.TMONYSE
Loading
Operating Income PerformanceStrong
Percentile Rank86
3Y CAGR-1.7%
5Y CAGR+0.5%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-1.7%/yr
vs +21.8%/yr prior
5Y CAGR
+0.5%/yr
Consistent
Acceleration
-23.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.11B | +5.8% |
| 2024 | $7.66B | +2.9% |
| 2023 | $7.45B | -12.7% |
| 2022 | $8.53B | -17.4% |
| 2021 | $10.32B | +30.7% |
| 2020 | $7.90B | +85.4% |
| 2019 | $4.26B | +10.0% |
| 2018 | $3.87B | +18.5% |
| 2017 | $3.27B | +14.3% |
| 2016 | $2.86B | - |